People · Operator
Named in public records as an officer, director or promoter · active 2023–2025 · Healthtech, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cala Health, Inc. | — | Healthtech | Series C | $166.1M | $370.1M | 2024 |
| Rune Labs, Inc. | — | Software / Tech | Series B | $56.6M | $60.1M | 2023 |
Jordi Parramon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jordi Parramon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Kim | 1 | 17 |
| Michael Carusi | 1 | 7 |
| John Kuelper | 1 | 6 |
| Michael A. Carusi | 1 | 6 |
| Renee Ryan | 1 | 6 |
| Justin Butler | 1 | 5 |
| Juan-Pablo Mas | 1 | 5 |
| James Lee | 1 | 5 |
| STACY ENXING SENG | 1 | 5 |
| Nicole Walker | 1 | 4 |
| ROBERT PAULL | 1 | 4 |
| NEIL TIWARI | 1 | 4 |
| MARK A. DEEM | 1 | 3 |
| ASHA NAYAK | 1 | 3 |
| Scott Delp | 1 | 2 |
| Ted A. Koutouzis | 1 | 2 |
| SERENA WONG | 1 | 2 |
| NEIL ENXING TIWARI | 1 | 1 |
| GREG ENXING SCHULTE | 1 | 1 |
| DEANNA HARSHBARGER | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.